Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers [1]

British Medical Journal

Volumn 332, Issue 7543, 2006, Pages 727-

  Welch, H Gilbert ^a   Schwartz, Lisa M ^a   Woloshin, Steven ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; LETTER; MAMMOGRAPHY; PRIORITY JOURNAL; PSEUDOTUMOR; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ERROR; FEMALE; MASS SCREENING; NOTE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; STANDARD; SWEDEN;

BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 33645501981     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006;332:689-92. (25 March.) doi:10.1136/bmj.38764.572569.7C (published 3 March 2006).
2. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-8.